S'abonner

Leveraging a Learning Collaborative Model to Develop and Pilot Quality Measures to Improve Opioid Prescribing in the Emergency Department - 20/02/24

Doi : 10.1016/j.annemergmed.2023.08.490 
Kathryn F. Hawk, MD, MHS a, , Scott G. Weiner, MD, MPH b, Craig Rothenberg, MPH a, Edward Bernstein, MD c, Gail D’Onofrio, MD, MS a, Andrew Herring, MD d, Jason Hoppe, DO e, Eric Ketcham, MD, MBA f, Alexis LaPietra, DO g, Lewis Nelson, MD, MBA h, Jeanmarie Perrone, MD i, Megan Ranney, MD, MPH j, Elizabeth A. Samuels, MD, MHS k, Reuben Strayer, MD l, Dhruv Sharma, MS m, Pawan Goyal, MD m, Jeremiah Schuur, MD, MHS n, Arjun K. Venkatesh, MD, MBA a
a Department of Emergency Medicine, Yale School of Medicine, New Haven, CT 
b Brigham and Women’s Hospital, Boston, MA 
c Boston Medical Center Department of Emergency Medicine, Boston, MA 
d Department of Emergency Medicine, Highland Hospital-Alameda Health System, University of California, San Francisco 
e Department of Emergency Medicine, University of Colorado School of Medicine, Denver 
f Presbyterian Healthcare, Espanola & Santa Fe, NM 
g Division of Emergency Medicine, RWJBarnabus Health, West Orange, NJ 
h Department of Emergency Medicine, Rutgers New Jersey Medical School, Newark 
i Department of Emergency Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia 
j Department of Health Policy and Management, Yale School of Public Health, New Haven, CT 
k UCLA Department of Emergency Medicine, Los Angeles, CA 
l Department of Emergency Medicine, Maimonides Medical Center, Brooklyn, NY 
m American College of Emergency Physicians, Dallas, TX 
n Department of Emergency Medicine, Brown School of Medicine, Providence, RI 

Corresponding Author.

Abstract

The American College of Emergency Physicians (ACEP) Emergency Medicine Quality Network (E-QUAL) Opioid Initiative was launched in 2018 to advance the dissemination of evidence-based resources to promote the care of emergency department (ED) patients with opioid use disorder. This virtual platform-based national learning collaborative includes a low-burden, structured quality improvement project, data benchmarking, tailored educational content, and resources designed to support a nationwide network of EDs with limited administrative and research infrastructure. As a part of this collaboration, we convened a group of experts to identify and design a set of measures to improve opioid prescribing practices to provide safe analgesia while reducing opioid-related harms. We present those measures here, alongside initial performance data on those measures from a sample of 370 nationwide community EDs participating in the 2019 E-QUAL collaborative. Measures include proportion of opioid administration in the ED, proportion of alternatives to opioids as first-line treatment, proportion of opioid prescription, opioid pill count per prescription, and patient medication safety education among ED visits for atraumatic back pain, dental pain, or headache. The proportion of benzodiazepine and opioid coprescribing for ED visits for atraumatic back pain was also evaluated. This project developed and effectively implemented a collection of 6 potential measures to evaluate opioid analgesic prescribing across a national sample of community EDs, representing the first feasibility assessment of opioid prescribing-related measures from rural and community EDs.

Le texte complet de cet article est disponible en PDF.

Plan


 Supervising editor: Donald M. Yealy, MD. Specific detailed information about possible conflict of interest for individual editors is available at https://www.annemergmed.com/editors.
 All authors attest to meeting the four ICMJE.org authorship criteria: (1) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND (2) Drafting the work or revising it critically for important intellectual content; AND (3) Final approval of the version to be published; AND (4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
 Funding and support: By Annals' policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org). This work was funded through grants from the Addiction Policy Forum and the NIDA Dissemination Initative. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies or stance, either expressed or implied, of the funding organizations. Outside of this work, SW is an advisory committee member of Vertex Pharmaceuticals, Inc. and Cessation Therapeutics, Inc. and is also employed by Bicycle Health. The rest of the authors report no such relationships.
 Meetings: Portions of this work were presented at the Society for Academic Emergency Medicine Conference in May 2021.


© 2023  American College of Emergency Physicians. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 83 - N° 3

P. 225-234 - mars 2024 Retour au numéro
Article précédent Article précédent
  • Atomized Intranasal Ketorolac Versus Intravenous Ketorolac for the Treatment of Severe Renal Colic in the Emergency Department: A Double-Blind, Randomized Controlled Trial
  • Usama Said Shannan Al-Khalasi, Awatif Khamis Said Al-Sarrai Al-Alalawi, Mahmood Al-Jufaili, Abdullah Al-Reesi, Ibrahim Al-Zakwani, Muzna Said Rashid Al-Asmi, Fatma Bader Al-Riyami, Ramesh Vishwakarma
| Article suivant Article suivant
  • Test Characteristics of Emergency Medicine-Performed Point-of-Care Ultrasound for the Diagnosis of Acute Cholecystitis: A Systematic Review and Meta-analysis
  • Samuel J. Wilson, Rajiv Thavanathan, Wei Cheng, Joanna Stuart, Daniel J. Kim, Peter Glen, Shauna Duigenan, Risa Shorr, Michael Y. Woo, Jeffrey J. Perry

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2026 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.